Skip to Content

Import Conditions

Search Import Questions Import Conditions Onshore Outcomes

Case: Highly refined organic chemicals and substances Effective 23 Dec 2020 to 05 Mar 2021

Import Conditions

Import conditions define the biosecurity requirements which must be met for your import. Where import conditions have been developed, they will be listed below.

Warnings and Information Notices
Information

This commodity has been included in the Automatic Entry Processing for Commodities (AEPCOMM) approved arrangement (AA). Accredited persons must refer to the onshore outcomes to determine if the consignment is in scope for the AA. Further information about the AEPCOMM AA is available in the Class 19.2 Requirements document.

Information

Fatty acids (e.g. docosahexaenoic acid (DHA) and arachidonic acid (ARA)) are considered organic acids and may be imported under the import conditions in this commodity case.

  1. A Department of Agriculture, Water and the Environment import permit is not required.

  2. These import conditions cover the importation of highly refined organic chemicals and substances as listed in Section 33 of the Biosecurity (Prohibited and Conditionally Non-prohibited Goods Determination) 2016.

  3. The goods must meet biosecurity requirements.

    To demonstrate compliance with this requirement you must present the following on a Product label, Invoice, Manufacturer's declaration, Exporter's declaration or Supplier's declaration:

    A statement that the product does not contain ingredients of animal, plant or microbial origin, other than highly processed and purified <<name of ingredient/s>> as listed in Section 33 of the Biosecurity (Prohibited and Conditionally Non-prohibited Goods Determination) 2016.

    OR

    Details of a full list of ingredients totalling 100%.

  4. These goods or any derivatives must not be distributed, sold or used for:

    1. animal consumption, or

    2. use as bioremedial agents or fertiliser, or

    3. veterinary therapeutic use.

  5. Each consignment of goods must be packed in clean and new packaging.

  6. Warnings and Information Notices
    Information

    Where applicable, the importer or end user must comply with:

    1. International (e.g.International Air Transport Association ) and domestic requirements concerning the safe handling, transport and labelling of biological material

    2. AS/NZS 2243 Safety in Laboratories standards

    3. Office of the Gene Technology Regulator (OGTR) requirements.

    4. State and Territory Departments of Health, and the Therapeutics Goods Administration (TGA).

  7. Commercial administrative conditions
    Documents must be provided with each consignment which:

    1. identify the consignment (if non-personal) e.g. entry number

    2. identify all goods being imported as part of this consignment e.g. invoice or waybill or importer’s manifest

    3. describe the goods being imported (where not clear).

      e.g. 1: Product XRab = Purified protein derived from rabbits

      e.g. 2: Product AX = Synthetic antibiotic

      e.g. 3: Comte = Cheese.

  8. Under the Biosecurity Charges Imposition (General) Regulation 2016 and Chapter 9, Part 2 of the Biosecurity Regulation 2016, fees are payable to the Department of Agriculture, Water and the Environment for all services. Detail on how the department applies fees and levies may be found in the Charging guidelines.

  9. In addition to the conditions for the goods being imported, non-commodity concerns must be assessed including container cleanliness, packaging and destination concerns, and may be subject to inspection and treatment on arrival. Please refer to the Non-Commodity Cargo Clearance BICON case for further information.

What happens next?

When you are importing into Australia a departmental officer will assess the risk posed by your import and determine the appropriate outcome to apply. You may use the link below to view the likely outcomes for this particular import scenario. Please be aware that the assessment conducted may result in an outcome that is not listed.

View Onshore Outcomes